Volume 8 • 2021 • Issue 3

FASTER, STRONGER, BETTER, NOW THAT THEY’RE TOGETHER The first-ever combination acetaminophen + ibuprofen pain reliever available in Canada. Indication 1 : COMBOGESIC® (acetaminophen 325 mg + ibuprofen 97.5 mg) is indicated in adults over 18 years for the short-term management of mild to moderate acute pain and the reduction of fever. For more information: Consult the Product Monograph at https://pdf.hres.ca/dpd_pm/00054759.PDF for important information regarding adverse reactions, drug interactions and dosing. The Product Monograph is also available by calling BioSyent Pharma Inc. at 1-888-439-0013 or at combogesic.ca. Reference: 1. COMBOGESIC® Product Monograph. BioSyent Pharma Inc. ©2021 BioSyent Pharma Inc. Combogesic.ca CO-2012-07 NEW AVAILABLE WITHOUT A PRESCRIPTION BEHIND THE PHARMACY COUNTER. Order your patient samples at combogesic.ca/dentist